Andrew Dickinson

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Andrew Dickinson

Andrew Dickinson

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Overview

Career Highlights

Myogen, Inc.
Gilead Sciences, Inc.
Immunomedics Inc.

RelSci Relationships

1342

Number of Boards

4

Birthday

1970

Age

50

Contact Data

Trying to get in touch with Andrew Dickinson? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals Andrew Dickinson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Brett A. Pletcher

Executive Vice President, Corporate Affairs & General Counsel at Gilead Sciences, Inc.

Relationship likelihood: Strong

Irv Weissman

Non-Resident Fellow at The Salk Institute for Biological Studies

Relationship likelihood: Strong

Ravindra Majeti

Associate Professor at Stanford University

Relationship likelihood: Strong

Behzad Aghazadeh

Managing Partner & Portfolio Manager at Avoro Capital Advisor LLC

Relationship likelihood: Strong

Scott A. Canute

Executive Director at Immunomedics Inc.

Relationship likelihood: Strong

Daniel O’Day

Chairman & Chief Executive Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Harout Semerjian

Former Chief Commercial Officer & Executive Vice President at Ipsen SA

Relationship likelihood: Strong

Mark Chao

Co-Founder at Forty Seven, Inc.

Relationship likelihood: Strong

Diane E. Wilfong

Senior Vice President, Corporate Controller & Chief Accounting Officer at Gilead Sciences, Inc.

Relationship likelihood: Strong

Linda Higgins

Senior Vice President & Head of External Innovation Center at Gilead Sciences, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

RelSci

November 2, 2020

Andrew Dickinson is now serving in a new position at Immunomedics Inc.

RelSci

November 2, 2020

Andrew Dickinson is now serving in a new board position at Immunomedics Inc.

Nasdaq

October 29, 2020

Gilead Sciences (GILD) Q3 2020 Earnings Call Transcript

FiercePharma

September 25, 2020

Immunomedics' deal mastermind in line for $2.35B payout after Gilead buy—despite the lack of a bidding war

Nasdaq

September 23, 2020

Gilead's seven-part M&A bond attracts heavy demand

Paths to Andrew Dickinson

Potential Connections via
Relationship Science

You

Andrew Dickinson

Executive Vice President & Chief Financial Officer at Gilead Sciences, Inc.

Education

Class of 1996

Loyola University Chicago

Loyola University Chicago, a private university founded in 1870 as St. Ignatius College, is one of the nation’s largest Jesuit, Catholic Universities and the only one located in Chicago. Loyola University Chicago comprises four campuses: Lake Shore (LSC), Water Tower (WTC), Health Sciences (HSC), and the John Felice Rome Center in Italy, and is home to ten schools and colleges: Quinlan School of Business, Marcella Niehoff School of Nursing, Stritch School of Medicine, College of Arts and Sciences, School of Communication, School of Continuing and Professional Studies, School of Education, School of Law, School of Social Work, and Graduate School. Loyola also features course locations in Beijing, China; Saigon-Ho Chi Minh City, Vietnam; Vernon Hills, Illinois (Cuneo Mansion and Gardens); and a Retreat and Ecology Campus in Woodstock, Illinois.

Class of 1993

The University of Colorado

The University of Colorado advances the economy, health and culture of Colorado and beyond, educating more than 435,000 students who have become catalysts in business, arts, health and community growth. CU’s four campuses feature top-tier faculty and hands-on learning opportunities in an environment where students thrive.

Career History

President, Treasurer & Director

2020 - Current

Immunomedics Inc.

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

President, Treasurer & Director

2020 - Current

Forty Seven, Inc.

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Executive Vice President & Chief Financial Officer

2016 - Current

Gilead Sciences, Inc.

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Political Donations

$250

2010

Langhorne C. Sias

Transactions

Details Hidden

STERIS Corporation purchases Synergy Health Ltd.

Details Hidden

GlaxoSmithKline Plc purchases Novartis AG /Human Vaccines Operations from Novartis AG

Details Hidden

Chiesi Farmaceutici SpA purchases Chiesi USA, Inc.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

Andrew Dickinson is affiliated with Immunomedics Inc., Forty Seven, Inc., Gilead Sciences, Inc., Myogen, Inc., Lazard Ltd., Kirkland & Ellis LLP, Cooley LLP, Lazard Freres & Co. LLC, Lazard & Co., Ltd.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Andrew Dickinson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Andrew Dickinson's profile does not indicate a business or promotional relationship of any kind between RelSci and Andrew Dickinson.